chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient arrived for her COVID vaccine and informed us prior to vaccine she was immunocompromised; however, her physician recommended she get the COVID vaccine. Patient received the COVID vaccine at 0920. Patient was informed to remain in the room where we were vaccinating for 30 minutes (due to immunocompromised status). ,  approximately 10 minutes after the vaccine was given patient started complaining of nausea. Patient escorted to exam room, and placed on exam table.  Patient complains of chills,  nausea, and joint pain.  She stated she did not eat today; juice and a snack bar provided.  Vital signs stable (BP = 108/73 - HR = 69), no apparent signs/symptoms of anaphylaxis. The doctor notified and agrees with a continued monitoring. Monitored for an additional 15 minutes, patient states she is feeling better. The nurse escorted patient to her car.  She was feeling better.  Unfortunately we wrote her phone number down wrong; however, we sent an email 12/30/20 am to check in.  Update 12/30/20 - The patient contacted the nurse via email, she is doing well - reports bicep area is hard with mild swelling and generalized body aches.
4OCT91 tc from mom states approx 1 hr post vax pt c/o not feeling well, climbed in moms lap & was pale, limp w/dec responsiveness but not unresponsive; t100-103 since shot; also c/o h/a; Pt seen by MD 4OCT91 & told was rxn-vs-viral illness;
After receiving all 4 vaccines, client immediately stated, "I don't feel good. I told her to put her head down and bring her knees to her chest. She then went limp for a few second, awoke and stated "wow what just happened?" 1429 Vital signs: B/P - 90/59, Pulse - 60 and respirations - 16. 1446 Vital Signs: B/P - 86/52, Pulse - 66 and respirations - 18.
Vaccinated 5/27/15. Fever started following day. Temp max 104.2.
Patient received the shot in the pharmacy and about an hour later, having already left the pharmacy, patient had to go to emergency room due to anaphylaxis
None at this time. First Hep A on 9-25-12. Second on 3-5-13 3 weeks too soon.
Patient accidently received a booster dose instead of a full second dose.  Gave the pt a second dose of booster to equal a full second dose.  This  was done about 20 minute span between both booster doses.
She reports that she had the Covid vaccine on 11/2/2021. On 11/8/2021 she started to have period like symptoms. She had ended her last period on 11/2/2021. She is usually very regular. She would like this reported as a vaccine reaction.
This spontaneous prospective pregnancy case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 27-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE for Hypothyroidism, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 02-Jul-2020 and the estimated date of delivery was 08-Apr-2021. On 09-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-seventh week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 09-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jul-2020, Pregnancy test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Estimated date of conception 16-Jul-2020. No treatment information provided.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 27-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Major fatigue, muscle pain through out body, intestinal flare up, dizziness, balancing problems, depression, tremors, cramping, concentration problems.  (Herbal supplements). 9/29/2009  VAERS report received with MR attached. Seen in ER 10/2/07 puncture wound Rt foot. Given vax and D/C.  ER visit 10/8/07 presented with C/O head pressure, dizzy, foggy vision, neck pressure, upset stomach, increase HR for 5 days. DX: Allergic RX to tetanus booster. ER visit 10/12/07 Presented with same sx as prev. ER visit. DX: medication rx. 10/30/07 ER visit presented with same sx as previous visit. DX: Arrhythmia, chest pressure, anorexia, pyuria.  Diagnostics/Labs: US Thyroid Enlarged Rt. lobe, tiny hyperechoic nodule Lt. lobe. ER visit 11/16/07and 11/26/07 Presented with C/O chest pain. ER visit 12/6/07 Presented with nausea and abdominal pain. DX: GERD related.
Information has been received from a health professional concerning a 13 and half week old female who on 28-JUN-2006 was vaccinated with a first oral dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine) due to a confusion with the birth date.  No problems were noted with administration.  There was no adverse event.  Unspecified medical attention was sought.  No product quality complaint was involved.  No other information was provided.  Additional information has been requested.
This morning, 30Aug2021, woke up and has swollen lymph nodes on one of sides; Once in a while, feels a little ache in the same location of the swollen lymph node; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 70 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 23Aug2021 (Lot number: FD8448) at the age of 70 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (ongoing), notes: Verbatim: High blood pressure. Concomitant medication(s) included: HYDROCHLOROTHIAZIDE taken for hypertension (ongoing); LISINOPRIL taken for hypertension (ongoing); ATENOLOL taken for hypertension (ongoing). Vaccination history included: Bnt162b2 (First dose: 30Jul2021 , Lot: FA7485, NDC: unknown , Expiration: Unknown , Route of administration: left arm), for Covid-19 Immunisation. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 30Aug2021, outcome "unknown", described as "This morning, 30Aug2021, woke up and has swollen lymph nodes on one of sides"; PAIN (non-serious) with onset 30Aug2021, outcome "unknown", described as "Once in a while, feels a little ache in the same location of the swollen lymph node".  Additional Information: Patient received the second dose Pfizer Covid 19 Vaccine on Monday, 23Aug2021, lot FD8448. This morning, 30Aug2021, has swollen lymph nodes on left hand side. The patient just noticed this morning when the patient woke up. agent asks if the swollen lymph nodes have improved, worsened or is persisting and the caller replies, the swollen lymph nodes happened this morning, 30Aug2021 and is pretty big and swollen lymph node is the size of the inside of the cup of palm of hand. The patient just noticed it this morning. Did not notice any swelling yesterday, 29Aug2021. Once in a while, the patient feels a little ache in the same location of the swollen lymph node and aching began about 5 hours ago today, 30Aug2021.   No follow-up attempts are possible. No further information is expected.
Right arm large (35mmx55mm) local reaction warm to touch, erythema, hard in center, c/o itching. Symptoms developed 24 hr after vaccination.
No adverse effects reported.  Patient requested a flu vaccine and was administered the Fluzone HD on 11/23/22.  Upon checking the record afterward, the pharmacy discovered that the patient had already received the Fluzone HD on 10/26/22.  The patient was confused and claimed she received the Pfizer booster on 10/26/22, but she actually got her Pfizer booster on 10/19/22 per her COVID vaccine card.
The vaccine just says DTaP. It was not specific to Infanrix.  Patient became ill and had a red target lesion measuring the size of a quarter on his right thigh. Unsure if the reaction was for the DTaP or Influenza. I will be following up with the healthcare provider to determine which vaccine caused the redness on the skin.
My left arm at injection site is still sore & aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP, Physician and Other HCP). The reporter is the patient.  A 65 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Apr2021 12:00 (Lot number: ER2613) at the age of 65 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Major depressive disorder" (unspecified if ongoing); "recurrent episode" (unspecified if ongoing); "Mild Sleep Apnea" (ongoing); "Hypertension" (ongoing); "obesity" (unspecified if ongoing); "Primary osteoarthritis of left hip" (unspecified if ongoing); "Cervical disc disease" (unspecified if ongoing); "Hypothyroid" (unspecified if ongoing); "Hyperlipemia" (unspecified if ongoing); "Chronic LBP" (unspecified if ongoing), notes: Chronic LBP; "HLD" (unspecified if ongoing), notes: HLD; "Headache" (unspecified if ongoing); "Myalgia" (unspecified if ongoing); "Sulfa (Sulfonamide Antibiotics)" (unspecified if ongoing); "Arthritis" (ongoing); "Depression" (ongoing); "Colitis" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN C [ASCORBIC ACID]; B-12; SIMVASTATIN; BUSPIRONE. Past drug history included: Colesevelam, reaction(s): "Drug Allergy"; Ezetimibe, reaction(s): "Drug Allergy"; Codiene, reaction(s): "Drug allergy"; Naproxen, reaction(s): "Drug Allergy"; Divalproex. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 05Apr2021, outcome "not recovered", described as "My left arm at injection site is still sore & aches". Therapeutic measures were taken as a result of vaccination site pain.  Additional information: If other vaccine in four weeks: No. AE treatment: Ice and heat. If COVID prior vaccination: No. If COVID tested post vaccination: No. Prior vaccination (within 4 weeks): None. Relevant tests: None. COVID vaccine details: Product: COVID 19, Brand: Pfizer, Lot number: EW0153, Administration date: 26Apr2021, Administration time: 11:45 AM, Dose number: 2, Vaccine location: Left arm.  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a 31-year-old male patient who was vaccinated with hepatitis A virus vaccine inactivated (manufacturer unknown).  Subsequently, 10 days post vaccination, the patient presented with a severe headache.  Additional information has been requested.
13DEC97 raised, red, bumpy rash like little pimples on legs where recv shots;16DEC97 legs improved, whitehead type bumps where each shot was given & scabs @ inj site;31DEC97 rash cleared 1wk ago, still has scabs where needle entered;
Left arm started swelling one day after shot, three days after shot swelling seems to be more.  Second day arm was very hot to the touch.  Third day arm is slightly less hot to touch but swelling looks worse.
Pt. states that after receiving the 1st dose of J&J 04/09/2021, started experiencing symptoms 07/2021 of heart racing, feet and hands tingling/burning  Neuropathy , feet swelling, and difficulty sleeping. Future Cardiologist appt. Dr.
shivering within 2 hours post dose/chilled; fever for 2 days; headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 03Oct2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete; Unknown manufacturer.), for Covid-19 Immunization. The following information was reported: PYREXIA (non-serious) with onset 03Oct2022, outcome "recovered" (05Oct2022), described as "fever for 2 days"; HEADACHE (non-serious) with onset 03Oct2022, outcome "unknown"; CHILLS (non-serious) with onset 03Oct2022, outcome "unknown", described as "shivering within 2 hours post dose/chilled". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of chills, pyrexia, headache.  Additional information: Excedrin provides some relief but headache returns. Event took place after use of product.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
I had Bells Palsey a few years ago and the symptoms came back very minor but hasn't gotten any better. Not complete paralysis on my fight side of face but reduced strength by more than 50%; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male consumer received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration in right arm on 08Apr2021 at 14:15 as single dose for COVID-19 immunization. Medical history of the patient included Bell's palsy (a few years ago) and known allergies (nine patient is aware of). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication received within 2 weeks of vaccination included cetirizine hydrochloride (ZYRTEC) for an unspecified indication. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in right arm on 25Mar2021 at 14:15 as single dose for COVID-19 immunization. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 09Apr2021 at 05:00, 14 hours 45 min after receiving second dose of vaccination, the symptoms of Bell's palsy came back very minor but had not gotten any better, not complete paralysis on patient's right side of face but reduced strength by more than 50 per cent. Outcome of the event was not resolved.  Information on the lot/batch number has been requested.
Patient is undergoing a cycle of immunotherapy for malignant neoplasm of posterior wall of urinary bladder and decided that he wanted a COVID vaccine. Patient came to the Outpatient Infusion, on 5/24/2022, to obtain a COVID vaccine that was ordered by his PCP.  The nurse gave the patient more than the order dose of COVID vaccine. Patient was informed and was seen at the Oncology clinic on 5/25/2022. Patient was feeling very well and exhibited no side effects.
Had Td shot at appointment on 10/6/2021. On Thursday (10/7/2021) started to have stinging numbness at base of left palm and left thumb when pressure applied. No problems at site of injection. Only when grabs something or push up with hand, gets pain all of a sudden. No symptoms when at rest. No trauma. When extends wrist, he gets pain on the thenar eminence of the left hand. The wrist is to be extended about 45degrees. When he doesn't push up against the wall there is no symptom.
Red blotches all over body; Very tired all of the time; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 30Mar2021 at 10:00 (at the age of 51-years-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient previously received codeine and experienced drug allergy. The patient did not receive any concomitant medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient experienced red blotches all over body - still 4 months later. The patient was very tired all of the time. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events red blotches all over body and very tired all of the time were not resolved at the time of this report.
within two weeks of receiving the vaccine the patient died; This is a spontaneous report based on information received by Pfizer from Merck & Co., Inc.    A contactable Consumer reported for a male patient of an unspecified age that received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation.  The patient medical history and the patient's concomitant medications were not reported.  The patient died within two weeks of receiving the vaccine on an unspecified date. It was not reported if an autopsy was performed.  No follow-up attempts are possible, information about lot/batch number cannot been obtained.; Reported Cause(s) of Death: within two weeks of receiving the vaccine both family members died
Red at injection site(4in. diameter); Itching at injection site; Swelling at injection site; Arm muscle feels hard; Burning at injection site; Tingling in scalp; Arm hurt for a couple of days; Arm very sore; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in scalp), VACCINATION SITE INDURATION (Arm muscle feels hard), VACCINATION SITE PAIN (Burning at injection site), VACCINATION SITE PAIN (Arm hurt for a couple of days) and VACCINATION SITE ERYTHEMA (Red at injection site(4in. diameter)) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX) for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm hurt for a couple of days) and VACCINATION SITE PAIN (Arm very sore). On 02-Feb-2021, the patient experienced PARAESTHESIA (Tingling in scalp). On 06-Feb-2021, the patient experienced VACCINATION SITE INDURATION (Arm muscle feels hard), VACCINATION SITE PAIN (Burning at injection site), VACCINATION SITE ERYTHEMA (Red at injection site(4in. diameter)), VACCINATION SITE PRURITUS (Itching at injection site) and VACCINATION SITE SWELLING (Swelling at injection site). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (Tingling in scalp), VACCINATION SITE INDURATION (Arm muscle feels hard), VACCINATION SITE PAIN (Burning at injection site), VACCINATION SITE PAIN (Arm hurt for a couple of days), VACCINATION SITE ERYTHEMA (Red at injection site(4in. diameter)), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE PAIN (Arm very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
After receiving FLUZONE HIGH-DOSE at the County Health Department on 10/04/2010, patient reported she began to feel ill that evening. She reported experiencing chills, body aches, left arm numbness and numbness in fingers on left hand. She also reported some numbness of two fingers on right hand. (The injection was given in the right deltoid). On 10/05/2010 she was seen by her medical provider complaining of the same numbness (as above), and non-productive cough. Body aches were reported to be better. Patient also reports seeing her medical provider on 10/11/2010 and 10/19/2010. The cough remained and the numbness had not progressed and appeared to be a little better, especially in right fingers. The numbness in the left fingers remained the same. She was treated with Hydrocodone, Prednisone, ZITHROMAX, and LEVAQUIN on different occasions. Because her condition did not improve, her medical provider recommended she see a specialist. On 10/29/2010, patient was seen by a neurologist. After a thorough exam, he plans to perform a "nerve test" on 11/5/2010 according to the patient. On 11/2/2010, patient reports she continues to feel tired; has hacky, dry cough; two mid-fingers on right hand remain numb; and thumb, midfinger and ring finger on left hand remain numb. She reports that the numbness of left fingers is worse than the numbness on the right fingers.
Localized redness and mild swelling around point of injection. Erythema 7 1/2 cm wide by 9 cm long.
Rec'd first covid vaccine at 11:04 am on 4/6/21. At 11:18am, experienced itchy throat, throat swelling, difficulty swallowing, dizziness and diaphoresis. Rec'd epipen 0.3mg in R thigh at 11:19am with positive effect. Transferred to ED for follow-up.
Injection site pain was present from the time of vaccine at 1pm. First onset of chills began around 9pm approximately 8 hours after vaccine. With the chills shortly after came body aches, muscle and joint pain and mild headache. This lasted through the night until around 8am on 8/19/21. The  injection site is still sore, the headache severity worse, and the patient is still feeling feverish. Over the counter Tylenol has been administered.
Positive result for covid-19; deferred vaccination for 90 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive result for covid-19) and INTENTIONAL PRODUCT USE ISSUE (deferred vaccination for 90 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Positive result for covid-19) and INTENTIONAL PRODUCT USE ISSUE (deferred vaccination for 90 days). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive result for covid-19) outcome was unknown and INTENTIONAL PRODUCT USE ISSUE (deferred vaccination for 90 days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant  medications provided. No treatment information provided.
Patient was given higher dose then recommended.  The pediatric dose was not mixed with dilution.   Patients parents were contacted of the error.  The patient had no adverse reaction.
Chronic achiness in left hand, arm continuing up to left side of the neck. Headache and neckache.